These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38606814)

  • 1. Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence.
    Bedini A; Elisi GM; Fanini F; Retini M; Scalvini L; Pasquini S; Contri C; Varani K; Spadoni G; Mor M; Vincenzi F; Rivara S
    J Pineal Res; 2024 Mar; 76(2):e12941. PubMed ID: 38606814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors.
    Elisi GM; Scalvini L; Lodola A; Mor M; Rivara S
    J Chem Inf Model; 2022 Jan; 62(1):210-222. PubMed ID: 34932329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
    Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
    J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XFEL structures of the human MT
    Johansson LC; Stauch B; McCorvy JD; Han GW; Patel N; Huang XP; Batyuk A; Gati C; Slocum ST; Li C; Grandner JM; Hao S; Olsen RHJ; Tribo AR; Zaare S; Zhu L; Zatsepin NA; Weierstall U; Yous S; Stevens RC; Liu W; Roth BL; Katritch V; Cherezov V
    Nature; 2019 May; 569(7755):289-292. PubMed ID: 31019305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT
    Mari M; Elisi GM; Bedini A; Lucarini S; Retini M; Lucini V; Scaglione F; Vincenzi F; Varani K; Castelli R; Mor M; Rivara S; Spadoni G
    Eur J Med Chem; 2022 Dec; 243():114762. PubMed ID: 36150258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro.
    Sampaio RV; Conceição S; Miranda MS; Sampaio Lde F; Ohashi OM
    Reprod Biol Endocrinol; 2012 Dec; 10():103. PubMed ID: 23207065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors.
    Legros C; Brasseur C; Delagrange P; Ducrot P; Nosjean O; Boutin JA
    J Pharmacol Exp Ther; 2016 Mar; 356(3):681-92. PubMed ID: 26759496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of the ligand binding and signaling mechanism of melatonin receptors.
    Wang Q; Lu Q; Guo Q; Teng M; Gong Q; Li X; Du Y; Liu Z; Tao Y
    Nat Commun; 2022 Jan; 13(1):454. PubMed ID: 35075127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors.
    Legros C; Matthey U; Grelak T; Pedragona-Moreau S; Hassler W; Yous S; Thomas E; Suzenet F; Folleas B; Lefoulon F; Berthelot P; Caignard DH; Guillaumet G; Delagrange P; Brayer JL; Nosjean O; Boutin JA
    Int J Mol Sci; 2013 Apr; 14(5):8948-62. PubMed ID: 23698757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational selective melatoninergic ligands for receptor subtype MT2.
    Wan N; Zhang FF; Ju J; Liu DZ; Zhou SY; Zhang BL
    Mini Rev Med Chem; 2013 Aug; 13(10):1462-74. PubMed ID: 23815579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6-Dihydroindolo[2,1-a]isoquinolines and Related Systems.
    Tsotinis A; Afroudakis PA; Papanastasiou IP; Sakellaropoulou A; Boniakou M; Komiotis D; Garratt PJ; Delagrange P; Bocianowska-Zbrog A; Sugden D
    ChemMedChem; 2022 Jun; 17(12):e202200129. PubMed ID: 35478275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides.
    Rivara S; Pala D; Lodola A; Mor M; Lucini V; Dugnani S; Scaglione F; Bedini A; Lucarini S; Tarzia G; Spadoni G
    ChemMedChem; 2012 Nov; 7(11):1954-64. PubMed ID: 22927210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the chicken brain melatonin-binding protein using iodinated and tritiated ligands.
    Kennaway DJ; Hugel HM; Rowe SA
    J Pineal Res; 1994 Oct; 17(3):137-48. PubMed ID: 7897586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding.
    Mazna P; Obsilova V; Jelinkova I; Balik A; Berka K; Sovova Z; Ettrich R; Svoboda P; Obsil T; Teisinger J
    J Neurochem; 2004 Nov; 91(4):836-42. PubMed ID: 15525337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
    Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
    Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene structures, biochemical characterization and distribution of rat melatonin receptors.
    Ishii H; Tanaka N; Kobayashi M; Kato M; Sakuma Y
    J Physiol Sci; 2009 Jan; 59(1):37-47. PubMed ID: 19340560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industrial and academic approaches to the search for alternative melatonin receptor ligands: An historical survey.
    Bedini A; Boutin JA; Legros C; Zlotos DP; Spadoni G
    J Pineal Res; 2024 May; 76(4):e12953. PubMed ID: 38682544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
    Hu Y; Chan KH; He X; Ho MK; Wong YH
    PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
    Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
    J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.